CaronElizabethRigdenMD
Oncology • Saint Peters, MOAssociate Professor, Internal Medicine, Washington University School of Medicine
Dr. Rigden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Entrance Way
# Dv
Saint Peters, MO 63376Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
Tulane UniversityResidency, Internal Medicine, 2000 - 2003- Tulane University School of MedicineClass of 2000
Certifications & Licensure
MO State Medical License 2004 - 2025
CT State Medical License 2003 - 2004
LA State Medical License 2001 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer Start of enrollment: 2011 May 10
- Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
- Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsNanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter,...Douglas Adkins, Jessica Ley, Omar Atiq, Steven Francis Powell, William C. Spanos
Oral Oncology. 2021-02-03 - 13 citationsGenomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong
Clinical Cancer Research. 2023-05-01 - 12 citationsRandomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgiaPolly A. Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie R. Nangia
Breast Cancer Research and Treatment. 2019-06-19
Journal Articles
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersHaeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
Authored Content
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020
Press Mentions
- Safety and Efficacy of Zimberelimab (AB122) in Combination with Domvanalimab (AB154) and Etrumadenant (AB928) in Patients with Previously Treated Non-Small Cell Lung CancerMarch 10th, 2021
Defactinib Combined with Pembrolizumab and Gemcitabine in Patients with Advanced CancerApril 18th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
